BlackRock
FLNA

BlackRock’s Filana Therapeutics FLNA Stock Holding History

BlackRock’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.39M Sell
1,414,514
-5,420
-0.4% -$11.2K ﹤0.01% 4085
2025
Q4 		$2.81M Buy
1,419,934
+10,778
+0.8% +$34.5K ﹤0.01% 4020
2025
Q3 		$4.1M Sell
1,409,156
-136,751
-9% -$314K ﹤0.01% 3854
2025
Q2 		$2.8M Sell
1,545,907
-1,929,073
-56% -$3.43M ﹤0.01% 3965
2025
Q1 		$5.21M Sell
3,474,980
-265,163
-7% -$669K ﹤0.01% 3634
2024
Q4 		$8.83M Buy
3,740,143
+476,669
+15% +$8.37M ﹤0.01% 3491
2024
Q3 		$96M Buy
3,263,474
+43,825
+1% +$1.01M ﹤0.01% 2110
2024
Q2 		$39.8M Buy
3,219,649
+174,185
+6% +$3.67M ﹤0.01% 2560
2024
Q1 		$61.8M Buy
3,045,464
+8,049
+0.3% +$185K ﹤0.01% 2319
2023
Q4 		$68.4M Buy
3,037,415
+198,431
+7% +$4.19M ﹤0.01% 2298
2023
Q3 		$47.2M Buy
2,838,984
+92,076
+3% +$1.82M ﹤0.01% 2424
2023
Q2 		$67.4M Buy
2,746,908
+124,231
+5% +$2.99M ﹤0.01% 2304
2023
Q1 		$63.3M Buy
2,622,677
+58,149
+2% +$1.61M ﹤0.01% 2291
2022
Q4 		$75.8M Buy
2,564,528
+78,807
+3% +$2.83M ﹤0.01% 2202
2022
Q3 		$104M Sell
2,485,721
-175,999
-7% -$4.75M ﹤0.01% 1935
2022
Q2 		$74.8M Sell
2,661,720
-42,161
-2% -$1.06M ﹤0.01% 2213
2022
Q1 		$100M Sell
2,703,881
-57,097
-2% -$2.42M ﹤0.01% 2134
2021
Q4 		$121M Buy
2,760,978
+157,100
+6% +$8.24M ﹤0.01% 2079
2021
Q3 		$162M Buy
2,603,878
+151,999
+6% +$12.7M ﹤0.01% 1880
2021
Q2 		$209M Buy
2,451,879
+46,957
+2% +$2.52M 0.01% 1722
2021
Q1 		$108M Buy
2,404,922
+434,153
+22% +$17.1M ﹤0.01% 2151
2020
Q4 		$13.4M Buy
1,970,769
+525,472
+36% +$4.69M ﹤0.01% 3219
2020
Q3 		$16.6M Sell
1,445,297
-22,278
-2% -$100K ﹤0.01% 2961
2020
Q2 		$4.52M Buy
1,467,575
+1,181,791
+414% +$5.36M ﹤0.01% 3561
2020
Q1 		$1.18M Buy
285,784
+570
+0.2% +$3.77K ﹤0.01% 3825
2019
Q4 		$1.48M Buy
285,214
+97,538
+52% +$168K ﹤0.01% 3878
2019
Q3 		$226K Buy
187,676
+413
+0.2% +$530 ﹤0.01% 4314
2019
Q2 		$226K Sell
187,263
-36,706
-16% -$41.6K ﹤0.01% 4340
2019
Q1 		$289K Sell
223,969
-2,097
-0.9% -$2.4K ﹤0.01% 4187
2018
Q4 		$193K Buy
226,066
+23,204
+11% +$26.7K ﹤0.01% 4239
2018
Q3 		$205K Buy
202,862
+859
+0.4% +$1.3K ﹤0.01% 4311
2018
Q2 		$416K Buy
202,003
+16,858
+9% +$145K ﹤0.01% 4148
2018
Q1 		$1.31M Sell
185,145
-794
-0.4% -$5.36K ﹤0.01% 3802
2017
Q4 		$743K Buy
185,939
+236
+0.1% +$953 ﹤0.01% 3977
2017
Q3 		$756K Buy
185,703
+400
+0.2% +$1.43K ﹤0.01% 3985
2017
Q2 		$769K Sell
185,303
-31,802
-15% -$150K ﹤0.01% 3915
2017
Q1 		$1.36M Buy
+217,105
New +$985K ﹤0.01% 3747
2014
Q2 		– Sell
-2
Closed – – 3212
2014
Q1 		$0 Buy
+2
New +$71 ﹤0.01% 3164

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock's FLNA Position: Q1 2026 in Review

BlackRock reduced its Filana Therapeutics (FLNA) stake by 0.38% in Q1 2026, selling an estimated $11.2K and leaving 1,414,514 shares worth $2.39M. The position accounts for ﹤0.01% of the portfolio, ranked #4085.

BlackRock first reported a position in FLNA in Q1 2014 and has held it in 38 quarters since. The position peaked at $209M in Q2 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • BlackRock held 1,414,514 shares of Filana Therapeutics worth $2.39M as of Q1 2026.
  • BlackRock sold 5,420 Filana Therapeutics shares in Q1 2026, an estimated $11.2K.
  • Filana Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #4085 holding.
  • BlackRock first reported a position in Filana Therapeutics in Q1 2014 and has held it in 38 quarters since.
  • BlackRock's Filana Therapeutics position peaked at $209M in Q2 2021.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.